Ratings by Aegis Capital (Nathan Weinstein)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/2/2025 | atai Life Sciences N.V | ATAI | Maintain | Buy (N/A) |
|
Details | ||
| 9/12/2022 | Evogene Ltd | EVGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/12/2022 | Stereotaxis | STXS | New Coverage | Buy (N/A) |
2.06 (1.87) |
-9.22% | Details | |
| 6/2/2022 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2022 | DarioHealth Corp. | DRIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | Harrow Health | HROW | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | Trevi Therapeutics | TRVI | New Coverage | Buy (N/A) |
2.16 (17.71) |
719.91% | Details | |
| 3/22/2022 | Entera Bio | ENTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2022 | Enveric Biosciences | ENVB | Downgrade | Hold (Buy) |
0.25 (1.33) |
432% | Details | |
| 2/15/2022 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2022 | DarioHealth Corp. | DRIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2021 | Chemomab Therapeutics | CMMB | New Coverage | Buy (N/A) |
7.43 (1.51) |
-79.68% | Details | |
| 11/1/2021 | Inspira Technologies Oxy B.H.N. Ltd. | IINN | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2021 | Kintara Therapeutics, Inc | KTRA | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2021 | Harrow Health | HROW | New Coverage | Buy (N/A) |
9.68 (42.41) |
338.12% | Details | |
| 9/22/2021 | Cidara Therapeutics | CDTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2021 | XOMA, Ltd. | XOMA | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2021 | atai Life Sciences N.V | ATAI | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2021 | Evogene Ltd | EVGN | New Coverage | Buy (N/A) |
2.94 (0.50) |
-82.99% | Details | |
| 7/8/2021 | atai Life Sciences N.V | ATAI | New Coverage | Buy (N/A) |
17.50 (4.05) |
-76.86% | Details | |
| 7/8/2021 | Enveric Biosciences | ENVB | New Coverage | Buy (N/A) |
2.08 (1.33) |
-36.06% | Details | |
| 6/29/2021 | XOMA, Ltd. | XOMA | New Coverage | Buy (N/A) |
32.31 (42.00) |
29.99% | Details | |
| 6/16/2021 | Kindred Biosciences | KIN | Downgrade | Hold (Buy) |
6.34 (9.25) |
45.9% | Details | |
| 6/8/2021 | Oramed Pharma | ORMP | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2021 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
14.52 (14.75) |
1.58% | Details | |
| 4/12/2021 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2021 | Entera Bio Ltd | ENTX | New Coverage | Buy (N/A) |
0.00 (1.48) |
0% | Details | |
| 3/15/2021 | CohBar | CWBR | New Coverage | Buy (N/A) |
1.44 (0.41) |
-71.53% | Details | |
| 3/4/2021 | Cidara Therapeutics | CDTX | New Coverage | Buy (N/A) |
2.23 (221.38) |
9827.35% | Details | |
| 3/2/2021 | MediWound Ltd | MDWD | New Coverage | Buy (N/A) |
5.48 (13.96) |
154.74% | Details | |
| 2/11/2021 | Marrone Bio Innovations | MBII | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2021 | DarioHealth Corp. | DRIO | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2021 | Kintara Therapeutics, Inc | KTRA | Maintain | Buy (N/A) |
|
Details | ||
| 1/26/2021 | Greenwich LifeSciences | GLSI | New Coverage | Buy (N/A) |
36.16 (23.75) |
-34.32% | Details | |
| 1/26/2021 | Kindred Biosciences | KIN | Maintain | Buy (N/A) |
|
Details | ||
| 10/19/2020 | Biomerica | BMRA | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2020 | VistaGen Therapeutics | VTGN | New Coverage | Buy (N/A) |
0.70 (0.64) |
-8.57% | Details | |
| 9/29/2020 | Dynatronics | DYNT | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2020 | Avinger | AVGR | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2020 | Kintara Therapeutics, Inc | KTRA | New Coverage | Buy (N/A) |
1.60 (0.22) |
-86.25% | Details | |
| 9/4/2020 | Biomerica | BMRA | Maintain | Buy (N/A) |
|
Details | ||
| 9/2/2020 | Acasti Pharma | ACST | Downgrade | Hold (Buy) |
0.22 (3.37) |
1431.82% | Details | |
| 8/19/2020 | VolitionRX | VNRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2020 | DarioHealth Corp. | DRIO | New Coverage | Buy (N/A) |
16.50 (6.34) |
-61.58% | Details | |
| 8/14/2020 | Marrone Bio Innovations | MBII | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2020 | Matinas BioPharma Holdings Inc. | MTNB | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2020 | Ekso Bionics | EKSO | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2020 | ImmuCell | ICCC | New Coverage | Buy (N/A) |
5.55 (9.75) |
75.68% | Details | |
| 6/19/2020 | Cardiovascular Systems | CSII | New Coverage | Buy (N/A) |
33.98 (20.00) |
-41.14% | Details | |
| 5/15/2020 | Avinger | AVGR | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2020 | VolitionRX | VNRX | New Coverage | Buy (N/A) |
4.18 (1.34) |
-67.94% | Details | |
| 4/23/2020 | SCYNEXIS | SCYX | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 4/2/2020 | Dynatronics | DYNT | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2020 | Anixa Biosciences | ANIX | New Coverage | Buy (N/A) |
1.85 (2.77) |
49.73% | Details | |
| 3/11/2020 | Oramed Pharma | ORMP | New Coverage | Buy (N/A) |
3.61 (4.01) |
11.08% | Details | |
| 1/30/2020 | Matinas BioPharma Holdings Inc. | MTNB | Maintain | Buy (N/A) |
|
Details | ||
| 1/29/2020 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | Dare Bioscience | DARE | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2020 | Matinas BioPharma Holdings Inc. | MTNB | New Coverage | Buy (N/A) |
1.64 (0.63) |
-61.59% | Details | |
| 11/22/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2019 | Stemline Therapeutics | STML | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2019 | Amarin Corporation | AMRN | New Coverage | Buy (N/A) |
16.36 (15.81) |
-3.36% | Details | |
| 9/12/2019 | Avinger | AVGR | New Coverage | Buy (N/A) |
1.14 (0.47) |
-58.77% | Details | |
| 9/9/2019 | OpGen | OPGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2019 | Dare Bioscience | DARE | New Coverage | Buy (N/A) |
0.79 (2.05) |
159.49% | Details | |
| 7/31/2019 | SCYNEXIS | SCYX | New Coverage | Buy (N/A) |
1.14 (3.80) |
233.33% | Details | |
| 7/24/2019 | Marrone Bio Innovations | MBII | New Coverage | Buy (N/A) |
1.37 (0.80) |
-41.61% | Details | |
| 7/9/2019 | Acasti Pharma | ACST | New Coverage | Buy (N/A) |
1.46 (0.22) |
-84.93% | Details | |
| 6/5/2019 | Dynatronics | DYNT | New Coverage | Buy (N/A) |
1.50 (0.24) |
-84% | Details | |
| 4/10/2019 | Kindred Biosciences | KIN | New Coverage | Buy (N/A) |
9.07 (9.25) |
1.98% | Details |
